Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
First Financial Bankshares
FFIN
$5.06B
| $5.85M | ﹤0.01% |
162,141
+38,118
| +31% | +$1.48M |
|
3677
CALL
Sprott Uranium Miners ETF
URNM
$2B
| $5.84M | ﹤0.01% |
145,000
-18,600
| -11% | -$866K |
|
3678
PUT
Warrior Met Coal
HCC
$5.19B
| $5.84M | ﹤0.01% |
107,700
-25,300
| -19% | -$1.62M |
|
3679
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $5.84M | ﹤0.01% |
61,009
-40,937
| -40% | -$4.03M |
|
3680
CALL
Exelixis
EXEL
$12.7B
| $5.83M | ﹤0.01% |
175,200
-61,200
| -26% | -$1.99M |
|
3681
Ouster
OUST
$3.51B
| $5.83M | ﹤0.01% |
477,104
+176,518
| +59% | +$1.55M |
|
3682
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $5.83M | ﹤0.01% |
203,417
+197,170
| +3,156% | +$5.76M |
|
3683
CALL
HEICO Corp
HEI
$52.4B
| $5.82M | ﹤0.01% |
24,500
-42,200
| -63% | -$10.9M |
|
3684
Ericsson
ERIC
$33.6B
| $5.82M | ﹤0.01% |
722,400
+687,881
| +1,993% | +$5.59M |
|
|
SAND
3685
DELISTED
Sandstorm Gold
SAND
| $5.81M | ﹤0.01% |
1,042,064
+580,323
| +126% | +$3.37M |
|
|
JOYY
3686
JOYY Inc
JOYY
$3.68B
| $5.81M | ﹤0.01% |
138,911
+55,557
| +67% | +$2.04M |
|
3687
Corcept Therapeutics
CORT
$12.4B
| $5.81M | ﹤0.01% |
115,221
-9,512
| -8% | -$498K |
|
|
RDFN
3688
DELISTED
Redfin
RDFN
| $5.81M | ﹤0.01% |
737,669
+369,981
| +101% | +$3.59M |
|
3689
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.05B
| $5.8M | ﹤0.01% |
269,225
+151,043
| +128% | +$3.31M |
|
|
ARR
3690
CALL
Armour Residential REIT
ARR
$2.37B
| $5.8M | ﹤0.01% |
307,560
+75,800
| +33% | +$1.45M |
|
3691
Nuvation Bio
NUVB
$2.18B
| $5.79M | ﹤0.01% |
2,177,962
-580,397
| -21% | -$1.49M |
|
3692
PUT
Cencora
COR
$59.9B
| $5.77M | ﹤0.01% |
25,700
-116,100
| -82% | -$27.3M |
|
3693
PUT
PTC
PTC
$16.2B
| $5.77M | ﹤0.01% |
31,400
+5,100
| +19% | +$967K |
|
3694
PUT
Xcel Energy
XEL
$49.5B
| $5.77M | ﹤0.01% |
85,500
-58,300
| -41% | -$3.91M |
|
3695
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
| $5.77M | ﹤0.01% |
32,414
+13,860
| +75% | +$2.52M |
|
|
DQ
3696
CALL
Daqo New Energy
DQ
$991M
| $5.77M | ﹤0.01% |
296,800
+32,400
| +12% | +$662K |
|
3697
PUT
Camtek
CAMT
$7.72B
| $5.77M | ﹤0.01% |
71,400
-63,600
| -47% | -$5M |
|
3698
PUT
Kyndryl
KD
$2.87B
| $5.76M | ﹤0.01% |
166,600
-151,600
| -48% | -$4.41M |
|
3699
PUT
iShares Core S&P Small-Cap ETF
IJR
$114B
| $5.76M | ﹤0.01% |
50,000
-2,800
| -5% | -$335K |
|
3700
Oscar Health
OSCR
$10.1B
| $5.76M | ﹤0.01% |
428,611
-4,039,637
| -90% | -$65M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.